Diagnosis of metabolic syndrome. Adaptation of diagnostic criteria in our setting. Recommendations of the Hdl forum;Diagnóstico de síndrome metabólico. Adecuación de los criterios diagnósticos en nuestro medio. Recomendaciones del foro HDL. Resumen ejecutivo

Revista Clinica Espanola

Volumn 206, Issue 11, 2006, Pages 576-582

  Ascaso, J F ^a,b   Gonzalez Santos P ^b   Hernandez Mijares A ^a,b   Mangas Rojas, A ^b   Masana Marin L ^b   Millan Nunez Cortes, J ^b,d   Pallardo, L F ^a   Pedro Botet, J ^b   Perez Jimenez F ^b   Pinto X ^b   Plaza, I ^c   Rubies Prat J ^b   Zuniga M ^b  

^a Sociedad Espanola de Diabetes   (Spain)

^b Centro de Atención Primaria Mar Báltico   (Spain)

^c Nuestra Senora de Guadalupe   (Spain)

^d HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN;

ANTHROPOMETRY; DIABETES MELLITUS; DIAGNOSTIC PROCEDURE; HUMAN; HYPERTENSION; INSULIN RESISTANCE; MEDICAL SOCIETY; METABOLIC SYNDROME X; PRACTICE GUIDELINE; PREVALENCE; REVIEW; RISK FACTOR;

EID: 33845963395     PISSN: 00142565     EISSN: None     Source Type: Journal    
DOI: 10.1157/13096308     Document Type: Article

References (40)

1. Cía Gómez P, Ćia Blasco P. Asociación de factores de riesgo (síndromes metabólicos). Medicina Cardiovascular. Arteriosclerosis. En: Millán J, editor. Barcelona: Masson; 2005. p. 471-83.
2. Álvarez León EE, Ribas Barba L, Serra Majem L. Prevalencia del síndrome metabólico en la población de la Comunidad Canaria. Med Clin (Barc). 2003;120:172-4.
3. Ascaso JF, Romero P, Real JT, Lorente RI, Martínez-Valls J, Carmena R. Abdominal obesity, insulin resistance, and metabolic syndrome in a southern European population. Eur J Intern Med. 2003;14:101-6.
4. Martínez Calatrava MJ, Martínez Larrad MT, Serrano Ríos M. Síndrome de resistencia a la insulina y síndrome metabólico: concepto, fisiopatología y epidemiología. Cardiovasc Risk Factors. 2003;12:89-95.
5. Álvarez Cosmea A, López Fernández V, Suárez García S, Arias García T, Prieto Díaz MA, Díaz González L. Diferencias en la prevalencia del síndrome metabólico según las definiciones del ATP-III y la OMS. Med Clin (Barc). 2005;124:368-70.
6. Alegría E, Cordero A, Laclaustra M, Grima A, León M, Casasnovas JA, et al. Prevalencia del síndrome metabólico en población laboral española: registro MESYAS. Rev Esp Cardiol. 2005;58:797-806.
7. Grundy SM, Hansen B, Smith SC Jr, Cleeman JL, Kahn RA. Clinical management of metabolic syndrome. Report of the National Heart, Lung, and Blood Institute/American Diabetes Association Conference on scientific issues related to management. Circulation. 2004;109:551-6.
8. Meigs JB. Invited commentary: insulin resistance syndrome? Syndrome X? Multiple metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated metabolic risk factors. Am J Epidemiol. 2000;152:908-11.
9. Reaven G. The metabolic syndrome or the insulin resistance syndrome? Different names, different concepts, and different goals. Endocrinol Metab Clin North Am. 2004;33:283-303.
10. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus: provisional report of a WHO consultation. Diabet Med. 1998;16:539-53.
11. Hanley AJG, Wagenknecht LE, D' Agostino RB Jr, Zimman B, Haffner SM. Identification of subjects with insulin resistance and beta-cell dysfunction using alternative definitions of the metabolic syndrome. Diabetes. 2003;52:2740-7.
12. Balkan B, Charles MA, Drirbholm T, Breh-Johnsen K, Wareham-Yudkin JS, Morris R, et al. The European Group for the Study of Insulin Resistance (EGIR). Frequency of the WHO metabolic syndrome in European cohorts, and alternative definition of in insulin resistance syndrome. Diabetes Metab. 2002;28:364-76.
13. Executive Summary of the Third Report of the National Cholesterol Education Program (NECP). Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285:2486-97.
14. Ford ES, Mokadal AH, Giles WH. Trends in waist circumference among U.S. adults. Obes Res. 2003;11:1223-31.
15. WHO Expert Consultation. Appropriate body mass index for Asian populations and is implications for policy and intervention strategies. Lancet. 2004;363:157-63.
16. Einhorn D, Reaven GM, Cobin RH, Ford E, Ganda OP, Handelsman Y, et al. American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract. 2003;9:237-52.
17. The IDF consensus worlwide definition of the metabolic syndrome. Disponible en: www.idf.org
18. Després JP, Couillard C, Bergeron J, Lamarche B. Regional body fat distribution, the insulin resistance-dyslipidemic syndrome and the risk of type 2 diabetes and the coronary heart disease. Handbook of Exercise in Diabetes. En: Ruderman N, editor. Alexandria: American Diabetes Association, p. 197-234.
19. Carr DB, Utzscheneider KM, Hull RL, Kodama K, Retzlaff BM, Brunzell JD, et al. Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes. 2004;53:2087-94.
20. American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 2004;27(Suppl.1):S5-S10.
21. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung and Blood Institute Scientific Statement. Circulation. 2005;112:2735-52.
22. Jiang X, Srinivisan Sr, Webber LS, Watigney WA, Berenson GS. Association of fasting insulin level with serum lipid and lipoprotein levels in children, adolescents, and young adults: the Bogalusa Heart Study. Arch Intern Med. 1995;155:190-6.
23. Ford Es, Giles WH. A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diabetes Care. 2003;26:575-81.
24. Weiss R, Dzima J, Burgert TS, Tumberlane Wr, Takgali SE, Yeckel CW, et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med. 2004;350:2362-74.
25. Cook S, Weitzman M, Aninger P, Nguyen M, Dietz WH. Prevalence of a metabolic syndrome phenotype in adolescents: Findings from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Pediatr Adolesc Med. 2003;157:821-7.
26. De Ferranti SD, Gauvreau K, Ludwig DS, Neufeld EJ, Newburger JW, Rifai N. Prevalence of the metabolic syndrome in American adolescents. Findings from the Third National Health and Nutrition Examination Survey. Circulation. 2004;110:2494-7.
27. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome. Prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med. 2003;163:427-36.
28. Hu G, Qiao A, Tuomilehto J, Balkau B, Borch-Johnsen K, Pyorala K; for the DECODE Study Group. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in non-diabetic European men and women. Arch Intern Med. 2004;164:1066-76.
29. Martínez de Morentin BE, Rodríguez MC, Martínez JA. Síndrome metabólico, resistencia a la insulina y metabolisme tisular. Endocrinol Nutr. 2003;50:324-33.
30. Álvarez A, López A, Suárez S, Arias T, Prieto MA, Díaz L. Diferencias en la prevalencia del síndrome metabólico según las definiciones del ATP-III y de la OMS. Med Clin (Barc). 2005;124:368-70.
31. Banegas JR, Villar F, Pérez C, Jiménez R, Gu E, Muñiz J, et al. Estudio epidemiológico de los factores de riesgo cardiovascular en la población española de 35 a 64 años. Rev San Hig Pub. 1993;67:419-45.
32. Gutiérrez-Fuentes JA, Gómez-Jerique J, Gómez A, Rubio MA, García A, Arístegui I. Dieta y riesgo cardiovascular en España DRECE II). Descripción de la evolución del perfil cardiovascular. Med Clin (Barc). 2000;115:726-9.
33. Aranceta J, Pérez C, Serra L, Ribas L, Quiles J, Vioque J, et al. Prevalencia de la obesidad en España: resultados del estudio SEEDO 2000. Med Clin (Barc). 2003;120:608-12.
34. Serra L, Ribas L, Aranceta J, Pérez C, Saavedra P, Peña L. Obesidad infantil y juvenil en España. Resultados del Estudio Enkid (1998-2000). Med Clin (Barc). 2003;121:725-32.
35. Villar F, Banegas JR, de Mata J, Rodríguez-Artalejo F. Las enfermedades cardiovasculares y sus factores de riesgo en España: hechos y cifras. Informe SEA 2003. Madrid: Ergon; 2003.
36. Goday A. Epidemiología de las diabetes y sus complicaciones no coronarias. Rev Esp Cardiol. 2002;55:657-70.
37. Gómez-Gerique JA, Gutiérrez JA, Montoya MT, Porres A, Rueda A, Avellaneda A, et al. Perfil lipídico en la población española: estudio DRECE (Dieta y Riesgo de Enfermedad Cardiovascular en España). Med Clin (Barc). 1999;113:730-5.
38. Santi MJ, Carrozas M, Toro R, Barba A, Astola A, Jiménez A, et al. La circunferencia de la cintura como predictor de resistencia insulínica en varones jóvenes. Clin Invest Arterioscler. 2005;17(extr.1):25.
39. Millán J, Mantilla T, Monereo S, Pérez C, Moreno B, Foz M, et al. Paramétros antropométricos asociados al riesgo cardiovascular en España. Estudio DORICA. Clin Invest Arterioscler. 2005;17(extr.1):28.
40. Aranceta J, Pérez C, Serra L, Vioque J, Tur JA, Mataix J, et al. Estudio DORICA: Dislipemia, Obesidad y Riesgo Cardiovascular. Obesidad y Riesgo Cardiovascular. En: Aranceta J, Foz M, Gil B, Jover E, Mantilla T, Millán J, et al editores. Editorial Panamericana; 2004;125-56.